Healthcare Sanofi Drug for Uncommon Blood Illness Is Heading to Recordati f…October 5, 2024 Sanofi’s Enjaymo, the one permitted drug remedy for a uncommon and debilitating blood dysfunction, is being acquired by Recordati in…
